REAL FERNANDEZ, FELICIANA
 Distribuzione geografica
Continente #
NA - Nord America 6.735
EU - Europa 3.121
AS - Asia 1.790
SA - Sud America 189
AF - Africa 64
OC - Oceania 42
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.943
Nazione #
US - Stati Uniti d'America 6.665
RU - Federazione Russa 1.081
PL - Polonia 819
SG - Singapore 508
CN - Cina 482
IT - Italia 332
HK - Hong Kong 298
SE - Svezia 244
IE - Irlanda 227
KR - Corea 174
BR - Brasile 149
CH - Svizzera 103
IN - India 92
DE - Germania 86
VN - Vietnam 71
FI - Finlandia 68
GB - Regno Unito 44
AU - Australia 42
ID - Indonesia 35
MX - Messico 31
CA - Canada 30
JO - Giordania 28
FR - Francia 24
ZA - Sudafrica 21
UA - Ucraina 20
CI - Costa d'Avorio 19
ES - Italia 19
TR - Turchia 17
NL - Olanda 15
IQ - Iraq 14
AR - Argentina 13
IR - Iran 13
JP - Giappone 12
EG - Egitto 11
AT - Austria 10
CZ - Repubblica Ceca 9
BD - Bangladesh 7
CO - Colombia 7
DK - Danimarca 7
EC - Ecuador 6
CL - Cile 5
MY - Malesia 5
AE - Emirati Arabi Uniti 4
BE - Belgio 4
IL - Israele 4
MA - Marocco 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
CR - Costa Rica 3
HN - Honduras 3
KZ - Kazakistan 3
PY - Paraguay 3
TH - Thailandia 3
VE - Venezuela 3
BG - Bulgaria 2
BY - Bielorussia 2
EU - Europa 2
KE - Kenya 2
NP - Nepal 2
PH - Filippine 2
TN - Tunisia 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
LB - Libano 1
LT - Lituania 1
LV - Lettonia 1
PE - Perù 1
PK - Pakistan 1
PS - Palestinian Territory 1
QA - Qatar 1
SA - Arabia Saudita 1
SN - Senegal 1
SV - El Salvador 1
ZW - Zimbabwe 1
Totale 11.943
Città #
Dallas 2.321
Santa Clara 1.346
Warsaw 809
Ashburn 419
Fairfield 345
Singapore 329
Hong Kong 240
Dublin 222
Chandler 198
Woodbridge 196
Beijing 167
Seoul 167
Seattle 153
Cambridge 130
Houston 130
Wilmington 109
Florence 103
Bern 100
Lawrence 79
Hefei 73
Altamura 72
Princeton 66
Buffalo 63
Los Angeles 60
Boston 49
Ann Arbor 44
Mumbai 43
New York 40
Moscow 38
Melbourne 35
Jakarta 28
Medford 28
Munich 28
San Diego 27
The Dalles 27
Boardman 24
Clifton 24
Shanghai 23
Helsinki 22
Kent 20
Abidjan 19
Dong Ket 16
Redondo Beach 16
Brooklyn 15
Guangzhou 15
Ho Chi Minh City 15
São Paulo 14
Jacksonville 13
Johannesburg 13
Milan 13
Norwalk 13
Philadelphia 13
London 12
Council Bluffs 11
Hanoi 11
Toronto 11
Falkenstein 10
Mexico City 10
Denver 9
Poplar 9
Ravenna 9
West Lafayette 9
Barcelona 8
Chicago 8
Dalian 8
Giza 8
Hillsboro 8
Redwood City 8
Turku 8
Bethesda 7
Brno 7
Frankfurt am Main 7
Lappeenranta 7
Montreal 7
Parma 7
Rio de Janeiro 7
Tokyo 7
Ankara 6
Bologna 6
Chennai 6
Columbus 6
Copenhagen 6
Izmir 6
Lauterbourg 6
Oklahoma City 6
Paris 6
Rome 6
Stockholm 6
Sydney 6
Andover 5
Atlanta 5
Bengaluru 5
Castellammare di Stabia 5
Da Nang 5
Dearborn 5
Ottawa 5
Phoenix 5
Siena 5
Tianjin 5
Vienna 5
Totale 8.912
Nome #
Antibodies from multiple sclerosis patients preferentially recognize hyperglucosylated adhesin of non-typeable Haemophilus influenzae 384
Immune dysfunction in Rett syndrome patients revealed by high levels of serum anti-N(Glc) IgM antibody fraction 352
Therapeutic proteins immunogenicity: a peptide point of view 333
Label-free method for anti-glucopeptide antibody detection in Multiple Sclerosis 329
Biosensor analysis of anti citrullinated protein/peptide antibodies (ACPA) affinity 298
Modified Glycopeptides to Investigate Antigen-Antibody Interaction in Multiple Sclerosis 267
The LIFE-MILCH study: first data on the exposure to Endocrine Disrupting Chemicals (EDCs) in urine and breast milk (BM) from end of pregnancy to 12 months of life. Abstract P1-245 ESPE 2024 62nd Annual Meeting of the European Society for Paediatric Endocrinology (ESPE) Liverpool, United Kingdom, November 16–18, 2024 264
Alpha actinin is specifically recognized by multiple sclerosis autoantibodies isolated using an N-glucosylated peptide epitope 237
The LIFE-MILCH project: preliminary data from the risk assessment model of exposure to Endocrine Disrupting Chemicals (EDCs) in mother-infant dyads during the first 3 months of life. ESPE 2024. Abstract RFC14, ESPE 2024 62nd Annual Meeting of the European Society for Paediatric Endocrinology (ESPE) Liverpool, United Kingdom, November 16–18, 2024 231
An Optimised Di-Boronate-ChemMatrix Affinity Chromatography to Trap Deoxyfructosylated Peptides as Biomarkers of Glycation 215
Glycopeptide-Based Antibody Detection in Multiple Sclerosis by Surface Plasmon Resonance 213
Antibodies to post-translationally modified mitochondrial peptide PDC-E2(167-184) in type 1 diabetes 213
A Multiple N-Glucosylated Peptide Epitope Efficiently Detecting Antibodies in Multiple Sclerosis 212
Anti-adalimumab antibodies in a cohort of patients with juvenile idiopathic arthritis: incidence and clinical correlations 210
A peptide-based anti-Adalimumab antibody assay to monitor immune response to biologics treatment in juvenile idiopathic arthritis and childhood chronic non-infectious uveitis 206
Role of Helical Structure in MBP Immunodominant Peptides for Efficient IgM Antibody Recognition in Multiple Sclerosis 196
Optimization of Multiple Sclerosis Antigenic Probes by a Combinatorial Approach 190
Study of aberrant modifications in peptides as test bench to investigate the immunological response to non-enzymatic glycation 190
Antibody Recognition in multiple sclerosis and rett syndrome using a collection of linear and cyclic N-glucosylated antigenic probes 189
Does an Aberrant Glucosylation Trigger Autoimmunity in Multiple Sclerosis? 185
Cross-reactive peptide epitopes of Enterovirus Coxsackie B4 and human Glutamic Acid Decarboxylase detecting antibodies in Latent Autoimmune Diabetes in Adults versus Type 1 Diabetes 184
Natural Triterpene Glycosides for Antibody Recognition 184
Aberrant post-translational modifications and autoimmunity: the case of Primary Biliary Cirrhosis 182
Detection of anti-adalimumab antibodies in a RA responsive cohort of patients using three different techniques 182
ANTIBODIES FROM MULTIPLE SCLEROSIS PATIENTS PREFERENTIALLY RECOGNIZE HYPER-GLUCOSYLATED ADHESIN OF NONTYPEABLE 178
CHARACTERIZATION OF RECOMBINANT HUMAN DOMAIN ANTIBODIES BY SURFACE PLASMON RESONANCE 175
Surface plasmon resonance-based methodology for anti-adalimumab antibody identification and kinetic characterization 173
Role of Lipoylation of the Immunodominant Epitope of Pyruvate Dehydrogenase Complex: Toward a Peptide-Based Diagnostic Assay for Primary Biliary Cirrhosis 173
N-glucosylated peptides of NogoR and OMGp proteins cross react with anti-hyperglucosylated adhesin of non-typeable Haemophilus influenzae antibodies in Multiple Sclerosis 172
Surface plasmon resonance method to evaluate anti-citrullinated protein/peptide antibody affinity to citrullinated peptides 169
Autoantibodies to N-glucosylated peptide sequons in Rett syndrome: the first insight to disclose an autoimmune mechanism. 167
DETECTION OF AUTOANTIBODIES IN PRIMARY BILIARY CIRRHOSIS USING PEPTIDES OF THE DIHYDROLIPOAMIDE ACETYLTRANSFERASE 166
Humoral response against LL-37 in psoriatic disease 166
Design, synthesis, and biological activity of tumor necrosis factor-alpha peptides for adalimumab recognition 165
Modeling interaction between gp120 HIV protein and CCR5 receptor 163
Combinatorial approach to develop the optimal glycopeptide as molecular probe to characterize autoantibodies in Multiple Sclerosis. 161
Human recombinant domain antibodies against multiple sclerosis antigenic peptide CSF114(Glc) 161
Histone Protein Epitope Mapping for Autoantibody Recognition in Rheumatoid Arthritis 160
Oleanane-type glycosides from the roots of Weigela florida "rumba" and evaluation of their antibody recognition 159
Microwave-assisted reaction of building blocks for glycopeptides synthesis. 159
SARS-CoV-2 inhibitory activity of a short peptide derived from internal fusion peptide of S2 subunit of spike glycoprotein 157
Nuovi peptidi glicosilati 156
Asparaginyl glucose is fundamental for autoantibody recognition in Multiple Sclerosis. 156
N-glucosylated adhesin peptide-dendrimers: toward a selective apheresis for personalized treatment of multiple sclerosis. 155
Glucopeptides derived from myelin-relevant proteins and hyperglucosylated nontypeable Haemophilus influenzae bacterial adhesin cross-react with multiple sclerosis specific antibodies: A step forward in the identification of native autoantigens in multiple sclerosis 154
Interactions between Human Antibodies and Synthetic Conformational Peptide Epitopes: Innovative Approach for Electrochemical Detection of Biomarkers of Multiple Sclerosis at Platinum Electrodes 154
Synthetic peptides reproducing tissue transglutaminase-gliadin complex neo-epitopes as probes for antibody detection in celiac disease patients’ sera. 152
The novel Boronic-ChemMatrix Resin to selectively fish out deoxyfructosylated peptides 149
Surface Plasmon Resonance to Select and Characterize Recombinant Human Domain Antibodies. 147
Synthesis of organometallic glycopeptides and electrochemical studies to detect autoantibodies in multiple sclerosis patients´ sera. 147
Selective capture of anti‐N‐glucosylated NTHi adhesin peptide antibodies by a multivalent dextran conjugate 146
Synthesis, conformational analysis and biological activity evaluation of novel antiviral peptides blocking the SARS-CoV-2 cell-entry 145
ELISA based on peptide antigens reproducing cross-reactive viral epitopes to detect antibodies in Latent Autoimmune Diabetes in Adults vs. Type 1 Diabetes 145
A surface-plasmon resonance-based label-free in vitro serodiagnostic technology for multiple sclerosis. 144
BIOSENSOR CHARACTERIZATION OF THE INTERACTION BETWEEN SYNTHETIC CITRULLINATED PEPTIDES AND AUTOANTIBODIES IN RHEUMATOID ARTHRITIS PATIENTS’ SERA 143
Epitope mapping of N-terminal portion of tissue transglutaminase protein antigen to identify linear epitopes in celiac disease. 139
Anti-hyperglucosylated adhesin of non-typeable Haemophilus influenzae antibodies cross reacting with glucopeptides of NogoR and OMGp myelin proteins 138
Surface plasmon resonance, fluorescence, and circular dichroism studies for the characterization of the binding of BACE-1 inhibitors 136
Electrochemical Glycopeptide Probes to Detect Autoantibodies in Multiple Sclerosis Patients’ Sera. 135
Structure-Activity Relationship Studies, SPR Affinity Characterization and Conformational Analysisof Peptides Mimicking the HNK-1 Carbohydrate Epitope 133
Characterisation of the minimal epitope detecting autoantibodies in Multiple Sclerosis by surface plasmon resonance 131
Interaction study of phospholipid membranes with an n-glucosylated β-turn peptide structure detecting autoantibodies biomarkers of multiple sclerosis 131
SPR-based biosensor analysis of autoantibodies from Rheumatoid Arthritis patients’ sera interacting with citrullinated Multiple Antigen Peptides 130
Hyperglucosylated adhesin-derived peptides as antigenic probes in multiple sclerosis: Structure optimization and immunological evaluation 127
Ferrocenyl Glycopeptides as Electrochemical Probes to Detect Autoantibodies in Multiple Sclerosis Patients’ Sera 110
Is aberrant N-glucosylation relevant to recognise anti-MOG antibodies in Rett syndrome? 106
INNOVATIVE ELECTROCHEMICAL DIAGNOSTIC DEVICES BASED ON SYNTHETIC CONFORMATIONAL PEPTIDE EPITOPE MIMICS 97
Totale 12.076
Categoria #
all - tutte 28.817
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.817


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021374 0 0 0 0 0 67 42 52 55 100 29 29
2021/2022467 17 55 41 36 32 14 6 35 15 17 65 134
2022/20231.080 108 213 46 59 63 161 154 44 96 9 22 105
2023/2024431 28 41 66 20 21 39 27 100 10 22 25 32
2024/20253.454 115 304 176 460 1.002 624 59 130 193 120 140 131
2025/20264.304 396 2.584 438 256 467 163 0 0 0 0 0 0
Totale 12.076